Ac-SHLVEALYLVCGERG-NH2

Ref. 3D-PP45410

Información del producto

• Nombre: Ac-SHLVEALYLVCGERG-NH2
• Sinónimos: Ac-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-amide

Descripción

Peptide Ac-SHLVEALYLVCGERG-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-SHLVEALYLVCGERG-NH2 include the following: C-terminal modification of the insulin B: 11-23 peptide creates superagonists in mouse and human type 1 diabetes Y Wang , T Sosinowski, A Novikov - Proceedings of the , 2018 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1716527115 Peptide-based approaches to treat lupus and other autoimmune diseases N Schall, N Page , C Macri , O Chaloin, JP Briand - Journal of , 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S089684111200073X Dual overlapping peptides recognized by insulin peptide B: 9-23 T cell receptor AV13S3 T cell clones of the NOD mouse N Abiru, D Wegmann, E Kawasaki, P Gottlieb - Journal of , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S089684110090369X T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8 MT Tran , P Faridi , JJ Lim , YT Ting , G Onwukwe - Nature , 2021 - nature.comhttps://www.nature.com/articles/s41467-021-25404-x Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes KH Lee, KW Wucherpfennig , DC Wiley - Nature immunology, 2001 - nature.comhttps://www.nature.com/articles/ni0601_501 A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes K Girdhar , Q Huang, IT Chow - Proceedings of the , 2022 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2120028119 Combined insulin B: 9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+ K Fukushima, N Abiru, Y Nagayama - Biochemical and , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X08000107 Emerging peptide therapeutics for inflammatory autoimmune diseases JP Briand, S Muller - Current pharmaceutical design, 2010 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2010/00000016/00000009/art00011 Simple method to introduce an ester infrared probe into proteins IA Ahmed , F Gai - Protein Science, 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pro.3076 and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide DG Alleva, A Gaur, L Jin, D Wegmann, PA Gottlieb - Diabetes, 2002 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/51/7/2126/34518 Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation AW Michels , DA Ostrov, L Zhang - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/187/11/5921/85492

• Marca: Biosynth